Fernwood Investment Management, LLC Bristol Myers Squibb CO Transaction History

Fernwood Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $23,990 - $27,200	500 New	500 $27,000
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $770,233 - $866,285	-12,980 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $57 - $65	1 Added 0.01%	12,980 $805,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $5,628 - $6,236	-98 Reduced 0.75%	12,979 $782,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $54 - $64	1 Added 0.01%	13,077 $769,000
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $606,726 - $881,714	13,076 New	13,076 $729,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.